GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » Debt-to-EBITDA

Medizen Humancare Co (XKRX:236340) Debt-to-EBITDA : -0.67 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medizen Humancare Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩667 Mil. Medizen Humancare Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩189 Mil. Medizen Humancare Co's annualized EBITDA for the quarter that ended in Dec. 2023 was ₩-1,273 Mil. Medizen Humancare Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.67.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Medizen Humancare Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:236340' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.92   Med: -0.94   Max: -0.67
Current: -0.67

During the past 7 years, the highest Debt-to-EBITDA Ratio of Medizen Humancare Co was -0.67. The lowest was -3.92. And the median was -0.94.

XKRX:236340's Debt-to-EBITDA is ranked worse than
100% of 101 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.76 vs XKRX:236340: -0.67

Medizen Humancare Co Debt-to-EBITDA Historical Data

The historical data trend for Medizen Humancare Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co Debt-to-EBITDA Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.90 -0.94 -2.34 -0.72 -0.67

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial -0.90 -0.94 -2.34 -0.72 -0.67

Competitive Comparison of Medizen Humancare Co's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Medizen Humancare Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medizen Humancare Co's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's Debt-to-EBITDA falls into.



Medizen Humancare Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medizen Humancare Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(667.441 + 189.411) / -1273.011
=-0.67

Medizen Humancare Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(667.441 + 189.411) / -1273.011
=-0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Dec. 2023) EBITDA data.


Medizen Humancare Co  (XKRX:236340) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Medizen Humancare Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medizen Humancare Co (XKRX:236340) Business Description

Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co (XKRX:236340) Headlines

No Headlines